During the fast-paced 'Lightning Round' of Mad Money Thursday night, Jim Cramer answered a caller about Cytosorbents (CTSO) : "You're fine with this one." Let's check out the charts of this maker of a unique blood purification therapy to control deadly inflammation in life-threatening illnesses in the ICU and cardiac surgery.
More from Investing
How the battle of value vs. growth stocks is resolved, we will have to wait and see.
JWN is not a retail name that looks constructive.
Here's our latest analysis and trading strategy for this retail name.
This one doesn't have options, so it would be a pure stock play now.